1-10 of 10
Claudia Schoch, M.D.
Close
Sort by
Journal Articles

Application of Multiparameter Flow Cytometry for the Identification of Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes.

Wolfgang Kern, MD, Claudia Schoch, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2006) 108 (11): 2615.
https://doi.org/10.1182/blood.V108.11.2615.2615
Published: 2006
Journal Articles

Correlation of Flow Cytometrically Determined Expression of ZAP-70 Using Two Different Antibodies with IgVH Mutation Status and Cytogenetics in 539 Patients with Chronic Lymphocytic Leukemia.

Wolfgang Kern, MD, Frank Dicker, Ph.D., Susanne Schnittger, Ph.D., Claudia Schoch, M.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2006) 108 (11): 495.
https://doi.org/10.1182/blood.V108.11.495.495
Published: 2006
Journal Articles

Use of 5-Fold Staining for Multiparameter Flow Cytometry-Based Quantification of Minimal Residual Disease in Acute Myeloid Leukemia Results in Improved Sensitivity.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 2025.
https://doi.org/10.1182/blood.V104.11.2025.2025
Published: 2004
Journal Articles

Identification of Biologically Distinct and Clinically Relevant Subentities in Patients with Acute Myeloid Leukemia and Normal Karyotypes by Use of Gene Expression Profiling.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Alexander Kohlmann, Ph.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 195.
https://doi.org/10.1182/blood.V104.11.195.195
Published: 2004
Journal Articles

Flow Cytometric Characterization of Genetically Defined Subgroups of Chronic Lymphocytic Leukemia: Basis for the Comprehensive Definition of Prognostic Parameters.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 4776.
https://doi.org/10.1182/blood.V104.11.4776.4776
Published: 2004
Journal Articles

Multiparameter Flow Cytometry Identifies Dysplasia in Granulocytic, Monocytic, and Erythrocytic Lineages and Blasts in Patients with Myelodysplastic Syndromes: Correlation with Cytomorphology and Cytogenetics.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, M.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 2376.
https://doi.org/10.1182/blood.V104.11.2376.2376
Published: 2004
Journal Articles

Determination of Minimal Residual Disease in Patients with Acute Myeloid Leukemia by Multiparameter Flow Cytometry: Prognostic Impact at Different Checkpoints.

Wolfgang Kern, M.D., Daniela Voskova, M.D., Claudia Schoch, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 400.
https://doi.org/10.1182/blood.V104.11.400.400
Published: 2004
Journal Articles

Minimal Residual Disease in Patients with Acute Myeloid Leukemia Quantified by Multiparameter Flow Cytomety and Quantitative RT-PCR Is an Independent Prognostic Parameter.

Wolfgang Kern, M.D., Claudia Schoch, M.D., Torsten Haferlach, M.D., Daniela Voskova, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 319.
https://doi.org/10.1182/blood.V104.11.319.319
Published: 2004
Journal Articles

Gene Expression Profiling in Adult Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia, and Acute Myeloid Leukemia M0: Confirmation of Immunophenotypic and Cytogenetic Diagnostic Findings.

Wolfgang Kern, M.D., Alexander Kohlmann, Claudia Schoch, M.D., Martin Dugas, M.D., Sylvia Merk, M.D., Wolfgang Hiddemann, M.D., Susanne Schnittger, Ph.D., Torsten Haferlach, M.D.
Journal: Blood
Blood (2004) 104 (11): 993.
https://doi.org/10.1182/blood.V104.11.993.993
Published: 2004
Journal Articles

Prognostic Impact of Cytogenetics and Early Response and Efficacy of Sequential High-Dose AraC and Idarubicin (S-HAI) in Patients with Refractory and Relapsed Acute Myeloid Leukemia (AML): Results of a Prospective Study.

Wolfgang Kern, M.D., Hubert Serve, M.D., Peter Staib, M.D., Christa Kerschgens, M.D., Anett Matylis, M.D., Karin Tischmann, M.D., Christoph Huber, M.D., Wolf D. Hirschmann, M.D., Hartmut Eimermacher, M.D., Johann G. Lange, M.D., Anke Zumsprekerl, M.D., Georg Maschmeyer, M.D., Michael Unterhalt, M.D., Jörn Ohnesorge, Maria C. Sauerland, Wolfgang Berdel, M.D., Thomas Büchner, M.D., Torsten Haferlach, M.D., Claudia Schoch, M.D., Wolf D. Ludwig, M.D., Wolfgang Hiddemann, M.D.
Journal: Blood
Blood (2004) 104 (11): 871.
https://doi.org/10.1182/blood.V104.11.871.871
Published: 2004